Oncology

Istock 2183695394 t H Nb Jh7gp2
Oncology
Novartis Acquires Myricx Bio in Deal Valued at Up to $1.5B
The company's approach delivers cancer-killing payload directly to tumor cells.
Featured
Akumin Mhi Ribbon Cutting
Imaging
Akumin Forms Joint Venture to Manufacture Relocatable Clinics
The company partnered with Wisconsin-based manufacturer CGS Premier.
June 23, 2026
Colo Sense Image
Oncology
FDA Approves First RNA-Based At-Home Colorectal Cancer Screening Test
It eliminates the need to separate or mix the stool sample.
June 22, 2026
An electromagnetic sensor integrated into a flex board assembly.
Electronic Components
What's at Stake When Designing Sensor-Enabled Devices
Successful micro-sensor integration is critical to designing devices that drive revolutionary medical innovations.
June 17, 2026
Skin Analytics Has Announced Derm Zero
Oncology
Smartphone App Provides Clinical-grade Skin Cancer Check
The device has earned the EU's highest medical device classification.
June 16, 2026
Gt Medical Technologies Gamma Tile Tile Based Radiation Therapy
Oncology
GT Medical Raises $100M for Brain Tumor Radiation Therapy Implant
It cuts down delays between surgery and radiation.
June 9, 2026
Top Headlines
This undated microscope image from USC via the NIH shows pancreatic cancer cells, nuclei in blue, growing as a sphere encased in membranes, red.
Experimental Pill Promises New Hope for Deadly Pancreatic Cancer
June 1, 2026
Olympus Corporation Bio Protect Balloon Space
Olympus Acquires BioProtect to Expand Its Urological Portfolio
May 26, 2026
Niowave Expansion Render 2025
Niowave Breaks Ground on $75M Cancer Therapies Production Facility
May 22, 2026
I Stock 2151484638
CQ Medical Enhances Cancer Treatment Capabilities with .Decimal Acquisition
May 6, 2026
I Stock 2189555731
Mapping Cancerous Tissue with a Hand-Held Probe
May 6, 2026
Siemens Healthineer Press Release Photon Flash Therapy Cancer Cell Image
Siemens Gets Up to $83M to Advance Photon Flash Radiotherapy for Cancer Care
May 5, 2026
Rs=w 1200,h 902,cg True
Utepreva Launches Single-Use Endometrial Sampling Device
April 22, 2026
I Stock 1291803607
FDA Advances Urine Test That Detects Multiple Forms of Cancer
April 14, 2026
Low Res Mitchell Lab Qjh 14
New Nanoparticle Could Unlock Universal Immunotherapy for Solid Cancers
March 18, 2026
I Stock 2167784408
Cryotherapy Could Be a Game Changer for Treating Early-Stage Kidney Cancer
March 6, 2026
I Stock 1460172015
Quantum Surgical Buys Johnson & Johnson's NeuWave Medical
February 26, 2026
Vocxi’s MyBreathPrint™ device platform translates chemical patterns in human breath into actionable clinical data.
Vocxi, Forj Medical Work to Miniaturize Breath-Based Cancer Detection Device Platform
February 25, 2026
Latest
Musk Says Neuralink Will Begin ‘High-Volume’ Production of Brain Implants
Sponsored
Musk Says Neuralink Will Begin ‘High-Volume’ Production of Brain Implants
The company is moving toward an almost entirely automated surgical procedure.
April 9, 2026
Yoga House Full
Devices
FDA Approves Novocure's Pancreatic Cancer Treatment Wearable
It delivers Tumor Treating Fields non-invasively.
February 12, 2026
I Stock 506877610
Oncology
Tiny Worm Offers Clues to Combat Chemotherapy Neurotoxicity
It affects up to 85% of cancer patients and survivors.
February 11, 2026
Ap26036565602781
Oncology
Pandemic Disruptions to Health Care Worsened Cancer Survival, Study Suggests
The researchers were not able to definitively show what drove worse survival.
February 5, 2026
Low Res Mit Ultrasound Patch 01 Press
Imaging
Portable Ultrasound Sensor May Enable Earlier Detection of Breast Cancer
The small probe is attached to a module that is a little larger than a smartphone.
February 2, 2026
Medtech
News
J&J Debuts Mobile Simulator App to Support Breast Augmentation Patients
It helps patients visualize potential outcomes during consultations.
January 30, 2026
The AMStent System is the first and only covered stent leveraging a decellularized human amniotic membrane (DCAM).
Oncology
Peytant AMStent® System Shows Reduced Airway Complications in Preclinical Model
Key findings include reduced complications, enhanced airway healing and potential for improved biocompatibility.
January 30, 2026
The MIM LesionID Pro
Home
GE HealthCare Gets FDA 510(k) Clearance for MIM LesionIDâ„¢ Pro
The platform could transform whole-body tumor burden analysis.
January 30, 2026
Scientists at Oregon State University have developed a new nanomaterial that triggers a pair of chemical reactions inside cancer cells, killing the cells via oxidative stress while leaving healthy tissues alone. It's an iron-based metal-organic framework that in cancer cells catalyzes the production of radical hydroxyls and singlet oxygen.
Oncology
New Cancer-Killing Material Developed by Nanomedicine Researchers
The findings advance the field of chemodynamic therapy.
January 28, 2026
Olympus Corporation Secure Flex Pr
Equipment
Olympus Launches Single-Use Fine Needle Biopsy Device in the U.S.
It's designed to enable the collection of large, intact tissue samples.
January 28, 2026
Low Res Melanie Rutkowski 04 Hr Da
Oncology
Victoria’s Secret Grant Backs Cutting-edge Ovarian Cancer Research
It will explore how faulty cellular signaling hurts the body’s ability to detect and fight.
January 9, 2026
Groves Doe Pilot Pr Image
Oncology
Oklo's Radioisotope Pilot Facility to Support Cancer Care, U.S. Medical Supply Chains
Today, many are produced overseas or in aging facilities.
January 7, 2026
I Stock 1572898538
Oncology
Ginkgo Bioworks, Carnegie-Mellon University to Develop New Cancer Screening Approach
The team expects to develop both a pill with sensors and a cancer screening device.
December 23, 2025
Astrin Biosciences logo.
Oncology
Astrin Biosciences Launches First Non-Imaging Breast Cancer Detection Test
The company's Certitude test will be available come early 2026.
December 4, 2025
Fabian R. Villagomez, Ph.D., a postdoctoral researcher in the Department of Biological Sciences at The University of Texas at El Paso, is studying high-grade serous carcinoma, an aggressive form of ovarian cancer. His work has helped identify a new target, Claudin-4, that may make the cancer cells more vulnerable to treatment.
Oncology
UTEP Researcher Finds Potential New Treatment for Aggressive Ovarian Cancer
Researchers target a protein to make cancer cells more vulnerable.
December 2, 2025